 | • レポートコード：MRC2-11QY08109 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はネツピタント-パロノセトロンFDCのグローバル市場について調査・分析したレポートです。種類別（フレーク、カプセル、その他）市場規模、用途別（小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ネツピタント-パロノセトロンFDCの競争状況、市場シェア ・世界のネツピタント-パロノセトロンFDC市場：種類別市場規模 2015年-2020年（フレーク、カプセル、その他） ・世界のネツピタント-パロノセトロンFDC市場：種類別市場規模予測 2021年-2026年（フレーク、カプセル、その他） ・世界のネツピタント-パロノセトロンFDC市場：用途別市場規模 2015年-2020年（小売薬局、オンライン薬局） ・世界のネツピタント-パロノセトロンFDC市場：用途別市場規模予測 2021年-2026年（小売薬局、オンライン薬局） ・北米のネツピタント-パロノセトロンFDC市場分析：米国、カナダ ・ヨーロッパのネツピタント-パロノセトロンFDC市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのネツピタント-パロノセトロンFDC市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のネツピタント-パロノセトロンFDC市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのネツピタント-パロノセトロンFDC市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eisai Pharmaceutical、Helsinn、Heron Therapeutics、Tesaro、Acacia Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The netupitant-palonosetron FDC is an oral therapy that targets two critical pathways associated with acute and delayed CINV by blockage of P/NK1 receptors. Netupitant in the central nervous system inhibits the binding of endogenous tachykinin neuropeptide substance, which prevents chemotherapy-induced nausea and vomiting (CINV).
Presently, patient pool segment has witnessed large-scale adoption of netupitant-palonosetron FDC drugs due to rise in number of patient undergoing chemotherapy.
Market Analysis and Insights: Global Netupitant-Palonosetron FDC Market
The global Netupitant-Palonosetron FDC market size is projected to reach US$ 305940 million by 2026, from US$ 279830 million in 2020, at a CAGR of 8.6%% during 2021-2026.
Global Netupitant-Palonosetron FDC Scope and Market Size
Netupitant-Palonosetron FDC market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Netupitant-Palonosetron FDC market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Netupitant-Palonosetron FDC market is segmented into
Flakes
Capsules
Other
Segment by Application, the Netupitant-Palonosetron FDC market is segmented into
Retail Pharmacy
Online Pharmacy
Regional and Country-level Analysis
The Netupitant-Palonosetron FDC market is analysed and market size information is provided by regions (countries).
The key regions covered in the Netupitant-Palonosetron FDC market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Netupitant-Palonosetron FDC Market Share Analysis
Netupitant-Palonosetron FDC market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Netupitant-Palonosetron FDC business, the date to enter into the Netupitant-Palonosetron FDC market, Netupitant-Palonosetron FDC product introduction, recent developments, etc.
The major vendors covered:
Eisai Pharmaceutical
Helsinn
Heron Therapeutics
Tesaro
Acacia Pharma
…
1 Study Coverage
1.1 Netupitant-Palonosetron FDC Product Introduction
1.2 Market Segments
1.3 Key Netupitant-Palonosetron FDC Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Netupitant-Palonosetron FDC Market Size Growth Rate by Type
1.4.2 Flakes
1.4.3 Capsules
1.4.4 Other
1.5 Market by Application
1.5.1 Global Netupitant-Palonosetron FDC Market Size Growth Rate by Application
1.5.2 Retail Pharmacy
1.5.3 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Netupitant-Palonosetron FDC Market Size, Estimates and Forecasts
2.1.1 Global Netupitant-Palonosetron FDC Revenue 2015-2026
2.1.2 Global Netupitant-Palonosetron FDC Sales 2015-2026
2.2 Global Netupitant-Palonosetron FDC, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Netupitant-Palonosetron FDC Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Netupitant-Palonosetron FDC Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Netupitant-Palonosetron FDC Competitor Landscape by Players
3.1 Netupitant-Palonosetron FDC Sales by Manufacturers
3.1.1 Netupitant-Palonosetron FDC Sales by Manufacturers (2015-2020)
3.1.2 Netupitant-Palonosetron FDC Sales Market Share by Manufacturers (2015-2020)
3.2 Netupitant-Palonosetron FDC Revenue by Manufacturers
3.2.1 Netupitant-Palonosetron FDC Revenue by Manufacturers (2015-2020)
3.2.2 Netupitant-Palonosetron FDC Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Netupitant-Palonosetron FDC Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Netupitant-Palonosetron FDC Revenue in 2019
3.2.5 Global Netupitant-Palonosetron FDC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Netupitant-Palonosetron FDC Price by Manufacturers
3.4 Netupitant-Palonosetron FDC Manufacturing Base Distribution, Product Types
3.4.1 Netupitant-Palonosetron FDC Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Netupitant-Palonosetron FDC Product Type
3.4.3 Date of International Manufacturers Enter into Netupitant-Palonosetron FDC Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Netupitant-Palonosetron FDC Market Size by Type (2015-2020)
4.1.1 Global Netupitant-Palonosetron FDC Sales by Type (2015-2020)
4.1.2 Global Netupitant-Palonosetron FDC Revenue by Type (2015-2020)
4.1.3 Netupitant-Palonosetron FDC Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Netupitant-Palonosetron FDC Market Size Forecast by Type (2021-2026)
4.2.1 Global Netupitant-Palonosetron FDC Sales Forecast by Type (2021-2026)
4.2.2 Global Netupitant-Palonosetron FDC Revenue Forecast by Type (2021-2026)
4.2.3 Netupitant-Palonosetron FDC Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Netupitant-Palonosetron FDC Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Netupitant-Palonosetron FDC Market Size by Application (2015-2020)
5.1.1 Global Netupitant-Palonosetron FDC Sales by Application (2015-2020)
5.1.2 Global Netupitant-Palonosetron FDC Revenue by Application (2015-2020)
5.1.3 Netupitant-Palonosetron FDC Price by Application (2015-2020)
5.2 Netupitant-Palonosetron FDC Market Size Forecast by Application (2021-2026)
5.2.1 Global Netupitant-Palonosetron FDC Sales Forecast by Application (2021-2026)
5.2.2 Global Netupitant-Palonosetron FDC Revenue Forecast by Application (2021-2026)
5.2.3 Global Netupitant-Palonosetron FDC Price Forecast by Application (2021-2026)
6 North America
6.1 North America Netupitant-Palonosetron FDC by Country
6.1.1 North America Netupitant-Palonosetron FDC Sales by Country
6.1.2 North America Netupitant-Palonosetron FDC Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Netupitant-Palonosetron FDC Market Facts & Figures by Type
6.3 North America Netupitant-Palonosetron FDC Market Facts & Figures by Application
7 Europe
7.1 Europe Netupitant-Palonosetron FDC by Country
7.1.1 Europe Netupitant-Palonosetron FDC Sales by Country
7.1.2 Europe Netupitant-Palonosetron FDC Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Netupitant-Palonosetron FDC Market Facts & Figures by Type
7.3 Europe Netupitant-Palonosetron FDC Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Netupitant-Palonosetron FDC by Region
8.1.1 Asia Pacific Netupitant-Palonosetron FDC Sales by Region
8.1.2 Asia Pacific Netupitant-Palonosetron FDC Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Netupitant-Palonosetron FDC Market Facts & Figures by Type
8.3 Asia Pacific Netupitant-Palonosetron FDC Market Facts & Figures by Application
9 Latin America
9.1 Latin America Netupitant-Palonosetron FDC by Country
9.1.1 Latin America Netupitant-Palonosetron FDC Sales by Country
9.1.2 Latin America Netupitant-Palonosetron FDC Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Netupitant-Palonosetron FDC Market Facts & Figures by Type
9.3 Central & South America Netupitant-Palonosetron FDC Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Netupitant-Palonosetron FDC by Country
10.1.1 Middle East and Africa Netupitant-Palonosetron FDC Sales by Country
10.1.2 Middle East and Africa Netupitant-Palonosetron FDC Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Netupitant-Palonosetron FDC Market Facts & Figures by Type
10.3 Middle East and Africa Netupitant-Palonosetron FDC Market Facts & Figures by Application
11 Company Profiles
11.1 Eisai Pharmaceutical
11.1.1 Eisai Pharmaceutical Corporation Information
11.1.2 Eisai Pharmaceutical Description and Business Overview
11.1.3 Eisai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eisai Pharmaceutical Netupitant-Palonosetron FDC Products Offered
11.1.5 Eisai Pharmaceutical Related Developments
11.2 Helsinn
11.2.1 Helsinn Corporation Information
11.2.2 Helsinn Description and Business Overview
11.2.3 Helsinn Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Helsinn Netupitant-Palonosetron FDC Products Offered
11.2.5 Helsinn Related Developments
11.3 Heron Therapeutics
11.3.1 Heron Therapeutics Corporation Information
11.3.2 Heron Therapeutics Description and Business Overview
11.3.3 Heron Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Heron Therapeutics Netupitant-Palonosetron FDC Products Offered
11.3.5 Heron Therapeutics Related Developments
11.4 Tesaro
11.4.1 Tesaro Corporation Information
11.4.2 Tesaro Description and Business Overview
11.4.3 Tesaro Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Tesaro Netupitant-Palonosetron FDC Products Offered
11.4.5 Tesaro Related Developments
11.5 Acacia Pharma
11.5.1 Acacia Pharma Corporation Information
11.5.2 Acacia Pharma Description and Business Overview
11.5.3 Acacia Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Acacia Pharma Netupitant-Palonosetron FDC Products Offered
11.5.5 Acacia Pharma Related Developments
11.1 Eisai Pharmaceutical
11.1.1 Eisai Pharmaceutical Corporation Information
11.1.2 Eisai Pharmaceutical Description and Business Overview
11.1.3 Eisai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eisai Pharmaceutical Netupitant-Palonosetron FDC Products Offered
11.1.5 Eisai Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Netupitant-Palonosetron FDC Market Estimates and Projections by Region
12.1.1 Global Netupitant-Palonosetron FDC Sales Forecast by Regions 2021-2026
12.1.2 Global Netupitant-Palonosetron FDC Revenue Forecast by Regions 2021-2026
12.2 North America Netupitant-Palonosetron FDC Market Size Forecast (2021-2026)
12.2.1 North America: Netupitant-Palonosetron FDC Sales Forecast (2021-2026)
12.2.2 North America: Netupitant-Palonosetron FDC Revenue Forecast (2021-2026)
12.2.3 North America: Netupitant-Palonosetron FDC Market Size Forecast by Country (2021-2026)
12.3 Europe Netupitant-Palonosetron FDC Market Size Forecast (2021-2026)
12.3.1 Europe: Netupitant-Palonosetron FDC Sales Forecast (2021-2026)
12.3.2 Europe: Netupitant-Palonosetron FDC Revenue Forecast (2021-2026)
12.3.3 Europe: Netupitant-Palonosetron FDC Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Netupitant-Palonosetron FDC Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Netupitant-Palonosetron FDC Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Netupitant-Palonosetron FDC Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Netupitant-Palonosetron FDC Market Size Forecast by Region (2021-2026)
12.5 Latin America Netupitant-Palonosetron FDC Market Size Forecast (2021-2026)
12.5.1 Latin America: Netupitant-Palonosetron FDC Sales Forecast (2021-2026)
12.5.2 Latin America: Netupitant-Palonosetron FDC Revenue Forecast (2021-2026)
12.5.3 Latin America: Netupitant-Palonosetron FDC Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Netupitant-Palonosetron FDC Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Netupitant-Palonosetron FDC Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Netupitant-Palonosetron FDC Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Netupitant-Palonosetron FDC Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Netupitant-Palonosetron FDC Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Netupitant-Palonosetron FDC Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Netupitant-Palonosetron FDC Market Segments
Table 2. Ranking of Global Top Netupitant-Palonosetron FDC Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Netupitant-Palonosetron FDC Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Flakes
Table 5. Major Manufacturers of Capsules
Table 6. Major Manufacturers of Other
Table 7. Global Netupitant-Palonosetron FDC Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global Netupitant-Palonosetron FDC Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global Netupitant-Palonosetron FDC Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Netupitant-Palonosetron FDC Sales Market Share by Regions (2015-2020)
Table 11. Global Netupitant-Palonosetron FDC Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Netupitant-Palonosetron FDC Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global Netupitant-Palonosetron FDC Sales Share by Manufacturers (2015-2020)
Table 14. Global Netupitant-Palonosetron FDC Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Netupitant-Palonosetron FDC by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Netupitant-Palonosetron FDC as of 2019)
Table 16. Netupitant-Palonosetron FDC Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Netupitant-Palonosetron FDC Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Netupitant-Palonosetron FDC Price (2015-2020) (USD/Pcs)
Table 19. Netupitant-Palonosetron FDC Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Netupitant-Palonosetron FDC Product Type
Table 21. Date of International Manufacturers Enter into Netupitant-Palonosetron FDC Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Netupitant-Palonosetron FDC Sales by Type (2015-2020) (K Pcs)
Table 24. Global Netupitant-Palonosetron FDC Sales Share by Type (2015-2020)
Table 25. Global Netupitant-Palonosetron FDC Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Netupitant-Palonosetron FDC Revenue Share by Type (2015-2020)
Table 27. Netupitant-Palonosetron FDC Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Netupitant-Palonosetron FDC Sales by Application (2015-2020) (K Pcs)
Table 29. Global Netupitant-Palonosetron FDC Sales Share by Application (2015-2020)
Table 30. North America Netupitant-Palonosetron FDC Sales by Country (2015-2020) (K Pcs)
Table 31. North America Netupitant-Palonosetron FDC Sales Market Share by Country (2015-2020)
Table 32. North America Netupitant-Palonosetron FDC Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Netupitant-Palonosetron FDC Revenue Market Share by Country (2015-2020)
Table 34. North America Netupitant-Palonosetron FDC Sales by Type (2015-2020) (K Pcs)
Table 35. North America Netupitant-Palonosetron FDC Sales Market Share by Type (2015-2020)
Table 36. North America Netupitant-Palonosetron FDC Sales by Application (2015-2020) (K Pcs)
Table 37. North America Netupitant-Palonosetron FDC Sales Market Share by Application (2015-2020)
Table 38. Europe Netupitant-Palonosetron FDC Sales by Country (2015-2020) (K Pcs)
Table 39. Europe Netupitant-Palonosetron FDC Sales Market Share by Country (2015-2020)
Table 40. Europe Netupitant-Palonosetron FDC Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Netupitant-Palonosetron FDC Revenue Market Share by Country (2015-2020)
Table 42. Europe Netupitant-Palonosetron FDC Sales by Type (2015-2020) (K Pcs)
Table 43. Europe Netupitant-Palonosetron FDC Sales Market Share by Type (2015-2020)
Table 44. Europe Netupitant-Palonosetron FDC Sales by Application (2015-2020) (K Pcs)
Table 45. Europe Netupitant-Palonosetron FDC Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Netupitant-Palonosetron FDC Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific Netupitant-Palonosetron FDC Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Netupitant-Palonosetron FDC Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Netupitant-Palonosetron FDC Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Netupitant-Palonosetron FDC Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific Netupitant-Palonosetron FDC Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Netupitant-Palonosetron FDC Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific Netupitant-Palonosetron FDC Sales Market Share by Application (2015-2020)
Table 54. Latin America Netupitant-Palonosetron FDC Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America Netupitant-Palonosetron FDC Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Netupitant-Palonosetron FDC Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Netupitant-Palonosetron FDC Revenue Market Share by Country (2015-2020)
Table 58. Latin America Netupitant-Palonosetron FDC Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America Netupitant-Palonosetron FDC Sales Market Share by Type (2015-2020)
Table 60. Latin America Netupitant-Palonosetron FDC Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America Netupitant-Palonosetron FDC Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Netupitant-Palonosetron FDC Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa Netupitant-Palonosetron FDC Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Netupitant-Palonosetron FDC Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Netupitant-Palonosetron FDC Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Netupitant-Palonosetron FDC Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa Netupitant-Palonosetron FDC Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Netupitant-Palonosetron FDC Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa Netupitant-Palonosetron FDC Sales Market Share by Application (2015-2020)
Table 70. Eisai Pharmaceutical Corporation Information
Table 71. Eisai Pharmaceutical Description and Major Businesses
Table 72. Eisai Pharmaceutical Netupitant-Palonosetron FDC Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Eisai Pharmaceutical Product
Table 74. Eisai Pharmaceutical Recent Development
Table 75. Helsinn Corporation Information
Table 76. Helsinn Description and Major Businesses
Table 77. Helsinn Netupitant-Palonosetron FDC Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Helsinn Product
Table 79. Helsinn Recent Development
Table 80. Heron Therapeutics Corporation Information
Table 81. Heron Therapeutics Description and Major Businesses
Table 82. Heron Therapeutics Netupitant-Palonosetron FDC Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Heron Therapeutics Product
Table 84. Heron Therapeutics Recent Development
Table 85. Tesaro Corporation Information
Table 86. Tesaro Description and Major Businesses
Table 87. Tesaro Netupitant-Palonosetron FDC Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Tesaro Product
Table 89. Tesaro Recent Development
Table 90. Acacia Pharma Corporation Information
Table 91. Acacia Pharma Description and Major Businesses
Table 92. Acacia Pharma Netupitant-Palonosetron FDC Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Acacia Pharma Product
Table 94. Acacia Pharma Recent Development
Table 95. Global Netupitant-Palonosetron FDC Sales Forecast by Regions (2021-2026) (K Pcs)
Table 96. Global Netupitant-Palonosetron FDC Sales Market Share Forecast by Regions (2021-2026)
Table 97. Global Netupitant-Palonosetron FDC Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 98. Global Netupitant-Palonosetron FDC Revenue Market Share Forecast by Regions (2021-2026)
Table 99. North America: Netupitant-Palonosetron FDC Sales Forecast by Country (2021-2026) (K Pcs)
Table 100. North America: Netupitant-Palonosetron FDC Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Europe: Netupitant-Palonosetron FDC Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. Europe: Netupitant-Palonosetron FDC Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Asia Pacific: Netupitant-Palonosetron FDC Sales Forecast by Region (2021-2026) (K Pcs)
Table 104. Asia Pacific: Netupitant-Palonosetron FDC Revenue Forecast by Region (2021-2026) (US$ Million)
Table 105. Latin America: Netupitant-Palonosetron FDC Sales Forecast by Country (2021-2026) (K Pcs)
Table 106. Latin America: Netupitant-Palonosetron FDC Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Middle East and Africa: Netupitant-Palonosetron FDC Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Middle East and Africa: Netupitant-Palonosetron FDC Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 110. Key Challenges
Table 111. Market Risks
Table 112. Main Points Interviewed from Key Netupitant-Palonosetron FDC Players
Table 113. Netupitant-Palonosetron FDC Customers List
Table 114. Netupitant-Palonosetron FDC Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Netupitant-Palonosetron FDC Product Picture
Figure 2. Global Netupitant-Palonosetron FDC Sales Market Share by Type in 2020 & 2026
Figure 3. Flakes Product Picture
Figure 4. Capsules Product Picture
Figure 5. Other Product Picture
Figure 6. Global Netupitant-Palonosetron FDC Sales Market Share by Application in 2020 & 2026
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Netupitant-Palonosetron FDC Report Years Considered
Figure 10. Global Netupitant-Palonosetron FDC Market Size 2015-2026 (US$ Million)
Figure 11. Global Netupitant-Palonosetron FDC Sales 2015-2026 (K Pcs)
Figure 12. Global Netupitant-Palonosetron FDC Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Netupitant-Palonosetron FDC Sales Market Share by Region (2015-2020)
Figure 14. Global Netupitant-Palonosetron FDC Sales Market Share by Region in 2019
Figure 15. Global Netupitant-Palonosetron FDC Revenue Market Share by Region (2015-2020)
Figure 16. Global Netupitant-Palonosetron FDC Revenue Market Share by Region in 2019
Figure 17. Global Netupitant-Palonosetron FDC Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Netupitant-Palonosetron FDC Revenue in 2019
Figure 19. Netupitant-Palonosetron FDC Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Netupitant-Palonosetron FDC Sales Market Share by Type (2015-2020)
Figure 21. Global Netupitant-Palonosetron FDC Sales Market Share by Type in 2019
Figure 22. Global Netupitant-Palonosetron FDC Revenue Market Share by Type (2015-2020)
Figure 23. Global Netupitant-Palonosetron FDC Revenue Market Share by Type in 2019
Figure 24. Global Netupitant-Palonosetron FDC Market Share by Price Range (2015-2020)
Figure 25. Global Netupitant-Palonosetron FDC Sales Market Share by Application (2015-2020)
Figure 26. Global Netupitant-Palonosetron FDC Sales Market Share by Application in 2019
Figure 27. Global Netupitant-Palonosetron FDC Revenue Market Share by Application (2015-2020)
Figure 28. Global Netupitant-Palonosetron FDC Revenue Market Share by Application in 2019
Figure 29. North America Netupitant-Palonosetron FDC Sales Growth Rate 2015-2020 (K Pcs)
Figure 30. North America Netupitant-Palonosetron FDC Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Netupitant-Palonosetron FDC Sales Market Share by Country in 2019
Figure 32. North America Netupitant-Palonosetron FDC Revenue Market Share by Country in 2019
Figure 33. U.S. Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 34. U.S. Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Canada Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Netupitant-Palonosetron FDC Market Share by Type in 2019
Figure 38. North America Netupitant-Palonosetron FDC Market Share by Application in 2019
Figure 39. Europe Netupitant-Palonosetron FDC Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. Europe Netupitant-Palonosetron FDC Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Netupitant-Palonosetron FDC Sales Market Share by Country in 2019
Figure 42. Europe Netupitant-Palonosetron FDC Revenue Market Share by Country in 2019
Figure 43. Germany Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Germany Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. France Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. U.K. Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Italy Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Russia Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Netupitant-Palonosetron FDC Market Share by Type in 2019
Figure 54. Europe Netupitant-Palonosetron FDC Market Share by Application in 2019
Figure 55. Asia Pacific Netupitant-Palonosetron FDC Sales Growth Rate 2015-2020 (K Pcs)
Figure 56. Asia Pacific Netupitant-Palonosetron FDC Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Netupitant-Palonosetron FDC Sales Market Share by Region in 2019
Figure 58. Asia Pacific Netupitant-Palonosetron FDC Revenue Market Share by Region in 2019
Figure 59. China Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. China Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Japan Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. South Korea Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. India Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Australia Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Taiwan Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Indonesia Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Thailand Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Malaysia Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Philippines Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Vietnam Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Netupitant-Palonosetron FDC Market Share by Type in 2019
Figure 82. Asia Pacific Netupitant-Palonosetron FDC Market Share by Application in 2019
Figure 83. Latin America Netupitant-Palonosetron FDC Sales Growth Rate 2015-2020 (K Pcs)
Figure 84. Latin America Netupitant-Palonosetron FDC Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Netupitant-Palonosetron FDC Sales Market Share by Country in 2019
Figure 86. Latin America Netupitant-Palonosetron FDC Revenue Market Share by Country in 2019
Figure 87. Mexico Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Mexico Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Brazil Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Argentina Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Netupitant-Palonosetron FDC Market Share by Type in 2019
Figure 94. Latin America Netupitant-Palonosetron FDC Market Share by Application in 2019
Figure 95. Middle East and Africa Netupitant-Palonosetron FDC Sales Growth Rate 2015-2020 (K Pcs)
Figure 96. Middle East and Africa Netupitant-Palonosetron FDC Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Netupitant-Palonosetron FDC Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Netupitant-Palonosetron FDC Revenue Market Share by Country in 2019
Figure 99. Turkey Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Turkey Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Saudi Arabia Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Netupitant-Palonosetron FDC Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. U.A.E Netupitant-Palonosetron FDC Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Netupitant-Palonosetron FDC Market Share by Type in 2019
Figure 106. Middle East and Africa Netupitant-Palonosetron FDC Market Share by Application in 2019
Figure 107. North America Netupitant-Palonosetron FDC Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 108. North America Netupitant-Palonosetron FDC Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Netupitant-Palonosetron FDC Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. Europe Netupitant-Palonosetron FDC Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Netupitant-Palonosetron FDC Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Asia Pacific Netupitant-Palonosetron FDC Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Netupitant-Palonosetron FDC Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Latin America Netupitant-Palonosetron FDC Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Netupitant-Palonosetron FDC Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Middle East and Africa Netupitant-Palonosetron FDC Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
CINV既存・パイプライン治療薬の世界市場（～2026年） Nausea and vomiting are the two most common side effects associated with cancer chemotherapy, and are referred to as chemotherapy induced nausea and vomiting (CINV). Market Analysis and Insights: Global CINV Existing and Pipeline Drugs Market The global CINV Existing and Pipeline Drugs market size i…- 外来患者用調剤自動化の世界市場（～2026年） The outpatient pharmacy automation system is a series of automated computer controlled workflows that minimize errors in pharmaceutical processes such as packaging and distribution. With the growing focus to reduce staffing and cut costs, there is a rise in the adoption of automation in the healthca…
- 非滅菌調剤薬の世界市場（～2026年） Nonsterile drug compounding is the practice of preparing specific medication doses for patients to drink, swallow, insert or apply to the skin. It is the most common kind of drug compounding done by pharmacists and pharmacy technicians in community and hospital pharmacies. And despite its "nonsteril…
- 動物用薬剤配合の世界市場（～2026年） Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as “customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient. Animal drug shortages are…
- ライ麦フレークの世界市場（～2026年） Market Analysis and Insights: Global Rye Flakes Market The global Rye Flakes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rye Flakes Scope and Market Size Rye Flakes market is segmented by Type, and by Application. …